共 50 条
- [41] The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer - The Khayat et al article reviewed ONCOLOGY-NEW YORK, 2001, 15 (04): : 430 - +
- [42] On the Road to Intraoperative Radiotherapy: More 'Proceed With Caution' Signs THE ASH ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (02): : 113 - +
- [43] Getting a Handle on Posttransplant Recurrence of HCC The Kim/Tan/Estfan et al Article Reviewed ONCOLOGY-NEW YORK, 2009, 23 (14): : 1287 - 1291
- [44] 'Unresectable' pancreatic cancer: Conceptual challenges - The Wisinski/Wahl/Small et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (13): : 1571 - 1572
- [45] Time to Move Beyond Clinical and Pathologic Classification of BAC THE LEVY ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2010, 24 (10): : 900 - 901
- [46] Understanding Evaluation and Management of Primary Cutaneous and Systemic ALCL The Querfeld et al article reviewed ONCOLOGY-NEW YORK, 2010, 24 (07): : 594 - 594
- [47] Neoadjuvant chemotherapy for ovarian cancer - The Vergote/Van Gorp/Amant et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (12): : 1628 - +
- [48] Proton Therapy for Prostate Cancer: Show Me the CER! THE HOPPE ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (07): : 652 - 657
- [49] Improved Understanding of Peripheral T-cell Lymphomas The Querfeld et al article reviewed ONCOLOGY-NEW YORK, 2010, 24 (07): : 587 - +
- [50] Transplant registries: Guiding clinical decisions and improving outcomes - The Horowitz et al article reviewed ONCOLOGY-NEW YORK, 2001, 15 (05): : 666 - 666